Plant-based therapies—including substances like psilocybin, MDMA-assisted therapy, and traditional plant medicines such as ayahuasca—are being explored in both research and carefully guided retreat settings for mental health and wellness. The goal is to create more pathways for healing that address the emotional, neurological, and spiritual dimensions of trauma.

As conversations around integrative mental health continue to grow, so does the language used to describe different therapeutic approaches. Terms like “psychedelic therapy,” “plant medicine,” and “ketamine treatment” are often used interchangeably, but they refer to distinct categories of substances and experiences.

A 2022 study from Johns Hopkins Medicine found that psilocybin-assisted treatment significantly reduced symptoms of major depressive disorder in adults, with effects that may last up to a year.